{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:37:09Z","timestamp":1773873429215,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.biologicals.2020.05.002","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T07:37:30Z","timestamp":1592638650000},"page":"21-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies"],"prefix":"10.1016","volume":"66","author":[{"given":"Peter","family":"Rigsby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Beamish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Hockley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Hitri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Novilia S.","family":"Bachtiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean C.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Goel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravipratapnarayan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Dugyala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Meiring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Mbewe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melita A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd","family":"Rijpkema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2020.05.002_bib1","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.biologicals.2020.05.002_bib2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(00)44360-6","article-title":"A new antigen of B. typhosus. Its relation to virulence and to active and passive immunisation","volume":"227","author":"Felix","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2020.05.002_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/150.3.436","article-title":"Re-examination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi","volume":"150","author":"Robbins","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2020.05.002_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.biologicals.2020.05.002_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0264-410X(94)90194-5","article-title":"Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines","volume":"12","author":"Keitel","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2020.05.002_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/INF.0b013e31812565bc","article-title":"Revaccination with locally-produced Vi typhoid polysaccharide vaccine among Chinese school-aged children: safety and immunogenicity findings","volume":"26","author":"Zhou","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.biologicals.2020.05.002_bib7","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1128\/IAI.67.11.5806-5810.1999","article-title":"Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam","volume":"67","author":"Kossaczka","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2020.05.002_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five- year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2020.05.002_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.biologicals.2020.05.002_bib10","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1016\/j.vaccine.2013.07.070","article-title":"Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate vaccines, Jeju, Republic of Korea, 5-7 September 2012","volume":"31","author":"Jones","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2020.05.002_bib11","first-page":"101","article-title":"WHO Guidelines on the quality, safety and efficacy of typhoid conjugate vaccines. 64th Meeting of the WHO Expert Committee on Biological Standardization","volume":"987","author":"WHO","year":"2014","journal-title":"WHO Tech Rep Ser"},{"key":"10.1016\/j.biologicals.2020.05.002_bib12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of Vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.biologicals.2020.05.002_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2020.05.002_bib14","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the typhoid conjugate vaccine pipeline current status and future plans","volume":"68","author":"Sahastrabuddhe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biologicals.2020.05.002_bib15","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Nanh","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2020.05.002_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.biologicals.2020.05.002_bib17","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biologicals.2020.05.002_bib18","series-title":"11th Int Conference on Typhoid and other invasive Salmonelloses","first-page":"p198","article-title":"Multipronged surveillance activities for identification of S. Typhi patients in Hyderabad: experience from XDR typhoid outbreak setting in Pakistan","author":"Yousafzai","year":"2019"},{"key":"10.1016\/j.biologicals.2020.05.002_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biologicals.2018.09.001","article-title":"Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG","volume":"56","author":"Rijpkema","year":"2018","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2020.05.002_bib20","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1128\/jcm.25.12.2266-2269.1987","article-title":"Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers","volume":"25","author":"Losonsky","year":"1987","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.biologicals.2020.05.002_bib21","first-page":"83","article-title":"Proposed First WHO International Standard for anti-Vi polysaccharide serum (human). 66th Meeting of the WHO Expert Committee on Biological Standardization, 12 to 16 October 2015","volume":"999","author":"WHO","year":"2015","journal-title":"WHO Tech Rep Series"},{"key":"10.1016\/j.biologicals.2020.05.002_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0022-1759(88)90317-1","article-title":"Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA","volume":"115","author":"Barra","year":"1988","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.biologicals.2020.05.002_bib23","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1128\/iai.59.12.4349-4356.1991","article-title":"Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C Meningococcal polysaccharides in sera from vaccinees and carriers","volume":"59","author":"Arakere","year":"1991","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.biologicals.2020.05.002_bib24","article-title":"The use of poly-L-lysine as a capture agent to enhance the detection of anti-nuclear antibodies by ELISA","volume":"9","author":"Stearns","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.biologicals.2020.05.002_bib25","first-page":"72","article-title":"First WHO International Standard for anti-typhoid capsular Vi polysaccharide immunoglobulin G (human). 68th Meeting of the WHO Expert Committee on Biological Standardization, 17 to 20 October 2017","volume":"1011","author":"WHO","year":"2018","journal-title":"WHO Tech Rep Ser"},{"key":"10.1016\/j.biologicals.2020.05.002_bib26","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.vaccine.2013.02.006","article-title":"A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned","volume":"31","author":"Szu","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2020.05.002_bib27","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.vaccine.2018.05.038","article-title":"Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: phase I trial in healthy Filipino adults and children","volume":"36","author":"Capeding","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2020.05.002_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2249.2004.02439.x","article-title":"Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors","volume":"136","author":"Ferry","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.biologicals.2020.05.002_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.biologicals.2020.05.002_bib31","first-page":"324","article-title":"A note on the concordance correlation coefficient","volume":"56","author":"Lin","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.biologicals.2020.05.002_bib32","unstructured":"R Core Team R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/Assessed.2018."}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:05Z","timestamp":1760922845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105620300609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":31,"alternative-id":["S1045105620300609"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.05.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}